SCHEMBL25818470

SCHEMBL25818470

Clc1nc(-c2cccc(-c3ccc4cccc(-c5cccc6ccccc56)c4c3)c2)nc(-c2ccc3sc4ccccc4c3c2)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.35
CYP1A2 P05177 4/20 0.34
ALDH1A1 P00352 2/20 0.34
ATM Q13315 2/20 0.34
HSD17B10 Q99714 2/20 0.34
CYP2C19 P33261 1/20 0.34
RAB9A P51151 1/20 0.34
ALOX5 P09917 1/20 0.34
PIM3 Q86V86 1/20 0.34
CA12 O43570 4/20 0.33
CA1 P00915 4/20 0.33
CA2 P00918 4/20 0.33
CA9 Q16790 4/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
MAPK1 P28482 1/20 0.33
NFKB2 Q00653 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25818483 0.94 KDM4E (0.34) KDM4ECYP1A2ALDH1A1ATMHSD17B10
SCHEMBL25818447 0.93 F9 (0.38) KDM4ECYP1A2ALDH1A1ATMHSD17B10
SCHEMBL25817798 0.92 ALOX5 (0.36) KDM4ECYP1A2ALDH1A1ATMHSD17B10
SCHEMBL22274495 0.90 KDM4E (0.37) KDM4ECYP1A2ALDH1A1ATMHSD17B10
SCHEMBL22161533 0.89 HSD17B1 (0.37) KDM4ECYP1A2ALDH1A1HSD17B10PIM3
SCHEMBL22161406 0.89 HDAC8 (0.37) KDM4ECYP1A2ALDH1A1ATMHSD17B10
SCHEMBL25818441 0.89 HSD17B1 (0.37) KDM4ECYP1A2ALDH1A1HSD17B10PIM3
SCHEMBL25818386 0.89 F9 (0.38) KDM4ECYP1A2ALDH1A1ATMHSD17B10
SCHEMBL25818402 0.88 GPR3 (0.33) KDM4ECYP1A2ALDH1A1HSD17B10PIM3
SCHEMBL25817821 0.88 PIM1 (0.36) KDM4EALDH1A1ATMHSD17B10RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 KDM4E 508/4885CYP1A2 1608/4885ALDH1A1 1010/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 KDM4E 508/4885CYP1A2 1608/4885ALDH1A1 1010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.